Spasov and Bratanov has advised Impetus Capital AD, through the investment fund ImVenture II KDA, on its equity investment in the start-up company Noesis. While the Covid pandemic came as a storm to the world economic, it also brought new opportunities for the pharmaceutical and cosmetic companies and Noesis did not miss its chance to grow and establish a name for itself during this difficult time. In addition with the corporate work related to the acquisition, Impetus also trusted us with the structuring of the financing for Noesis through a series of convertible loans and the all-around legal service in connection with the transaction. The partner Boyko Bratanov and the associates Vladimir Tashev and Krasimir Mitkov, working closely with the client, yet again accomplished great results.

Date: November 2022
Source: Spasov & Bratanov Lawyers’ Partnership

PRACTICES

More Posts

Spasov and Bratanov has advised VP Brands International AD on its acquisition of 100% of

Read More »

Spasov and Bratanov advises Impetus Capital and ImVenture II with the investment in the Delaware

Read More »

Spasov and Bratanov was once again entrusted with providing legal support to ImVenture II KDA,

Read More »

Recently the European Commission endorsed the recovery and resilience plan of Bulgaria, which the President

Read More »

Share: